Implementation of a System-level Tobacco Treatment Intervention
NCT02816697
Behavior, Health Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT Number: NCT01309087
The primary objective of this study is to substantiate prediction accuracy(with a tighter 95% confidence interval compared to current diagnostic modalities), of a lung cancer biomarker for risk stratification of patients into high and low risk categories to aid in clinical evaluation of the patient.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
University of British Columbia, Vancouver, British Columbia, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One year from enrollment
Allegro Diagnostics, Corp.
Industry
Acronym: AEGIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02816697
Behavior, Health Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05362318
Behavior, Lung Cancer
Tampa, Florida, United States
View Trial DetailsNCT04308226
Behavior, Homelessness
Boston, Massachusetts, United States
View Trial DetailsNCT03891602
Behavior, Cigarette Smoking
Seattle, Washington, United States
View Trial Details